The gap between two Covishield Covid-19 vaccine doses should be increased to 12-16 weeks, a government panel has recommended. However, no Covaxin dosage gap suggested by the National Technical Advisory Group on Immunisation or NTAGI.
“Based on the available real-life evidence particularly from the UK, the Covid-19 working group agreed for increasing the dosing interval to 12-16 weeks between two doses of Covishield vaccine. No change in an interval of Covaxin vaccine doses was recommended,” news agency PTI has reported quoting sources. Currently, the recommended gap between two Covishield doses is four to eight weeks.
The government panel also suggested that pregnant women may be given an offer to be able to choose from receiving any Covid-19 vaccine. Also, lactating women can be vaccinated any time after delivery.
The government panel also said that people who have a proven laboratory test for SARS-CoV-2 illness should defer vaccination against Covid-19 infection for six months after recovery. As per the present protocol, the vaccine must be taken four to eight weeks post-recovery Covid-19 infection recovery.
These recommendations of NTAGI will now be sent to the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC). Its recommendations come amid several states reporting a shortage of Covid-19 vaccines.
Several states and UTs, including Maharashtra, Karnataka, Uttar Pradesh, Odisha, Andhra Pradesh, Telangana, and Delhi have taken the decision for opting for global tenders to procure anti-coronavirus doses as the domestic vaccine supply falling short of meeting the rising demand.